@article{9749ed09a46a46fb9eb0481b6fe2f963,
title = "Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response",
keywords = "JANUS KINASE INHIBITOR, JAK INHIBITOR, METHOTREXATE, ACTIVATION, INTERLEUKIN-6, ETANERCEPT, EXPRESSION, CP-690,550, THERAPY, STAT, Therapy, Activation, Jak inhibitor, Oncostatin m, Interleukin-6, Etanercept, Expression, Cp-690,550, Methotrexate, Janus kinase inhibitor, 3121 General medicine, internal medicine and other clinical medicine, 3111 Biomedicine",
author = "Atte Valli and Krista Kuuliala and Anniina Virtanen and Antti Kuuliala and Maaria Palmroth and Ritva Peltomaa and Krista-Liisa Vidqvist and Marjatta Leirisalo-Repo and Olli Silvennoinen and Pia Isom{\"a}ki",
year = "2022",
month = dec,
day = "15",
doi = "10.1093/cei/uxac085",
language = "English",
volume = "210",
pages = "141--150",
journal = "Clinical and Experimental Immunology",
issn = "0009-9104",
publisher = "Wiley/Blackwell ",
number = "2",
}